Receiving a diagnosis of Major Depressive Disorder (MDD) can feel overwhelming, but it’s also a crucial first step toward healing. An MDD diagnosis means that you’ve been experiencing persistent symptoms like a pervasive low mood, loss of interest or pleasure, changes in sleep or appetite, fatigue, feelings of worthlessness, or difficulty concentrating, for at least two weeks, […]
Starting an antidepressant is a significant, often hopeful, step toward managing depression. For many, it marks the beginning of feeling more like themselves again. However, the journey to feeling truly well isn’t always a straight line. Finding the “just right” dose of medication for your unique brain chemistry can take time and requires open, honest communication
Living with depression can feel like being caught in a storm, even when the South Florida sun is shining brightly outside. While the region is known for its vibrant lifestyle and beautiful beaches, it’s also home to a robust mental health community offering a diverse array of therapies for depression. The key to finding relief often
Depression is a pervasive mental health condition that affects millions worldwide. It’s more than just feeling sad; it’s a serious mood disorder that can significantly impact how you feel, think, and handle daily activities. A common question for those experiencing depression, and for their loved ones, is: “Does depression go away?” The answer, while nuanced,
When someone is battling both depression and addiction, the struggle can feel overwhelming. Each condition fuels the other, making recovery far more complex than treating one issue alone. Yet for many, this is the reality—and it demands a comprehensive solution. That’s where integrated care comes in: a compassionate, evidence-based approach that treats both depression and
Spravato is the brand-name for esketamine nasal spray, a groundbreaking medication approved by the FDA in March 2019 for adults with treatment‑resistant depression (TRD)—that is, individuals who haven’t experienced adequate relief after at least two proven antidepressant. Esketamine is the S-enantiomer of ketamine and acts as a NMDA receptor antagonist, modulating glutamate pathways involved in
